Shanjin Capital — Email, Phone & Partners

Overview

Shanjin Capital is a private equity firm based in Shanghai, China, specializing in investments within the healthcare and technology sectors. The firm is approved by the Asset Management Association of China and primarily invests in clean energy, connected vehicles, medtech, and healthcare. Shanjin Capital's portfolio includes companies in biotechnology, artificial intelligence, robotics, semiconductor, electronics, telecommunications, and wireless communications infrastructure. The firm engages in various investment stages, including seed, early stage, series A, series B, growth, late stage, pre-IPO, buyout, turnaround, and distressed investments, with a geographical focus on China. Shanjin Capital's investment strategy emphasizes value creation and return on investment, leveraging its international presence and flexible systems to align shareholder, business, and social values. The firm has a track record of active investments, with recent deals in companies such as GenFleet Therapeutics, Echemi, and CorEnergy Semiconductor. Shanjin Capital's approach combines internationalization with flexible systems to achieve the organic unity of shareholder value, business value, and social value. The firm has a history of active investments, with recent deals in companies such as GenFleet Therapeutics, Echemi, and CorEnergy Semiconductor. Shanjin Capital's approach combines internationalization with flexible systems to achieve the organic unity of shareholder value, business value, and social value. Shanjin Capital is a private equity firm based in Shanghai, China, specializing in investments within the healthcare and technology sectors. The firm is approved by the Asset Management Association of China and primarily invests in clean energy, connected vehicles, medtech, and healthcare. Shanjin Capital's portfolio includes companies in biotechnology, artificial intelligence, robotics, semiconductor, electronics, telecommunications, and wireless communications infrastructure. The firm engages in various investment stages, including seed, early stage, series A, series B, growth, late stage, pre-IPO, buyout, turnaround, and distressed investments, with a geographical focus on China. Shanjin Capital's investment strategy emphasizes value creation and return on investment, leveraging its international presence and flexible systems to align shareholder, business, and social values. The firm has a track record of active investments, with recent deals in companies such as GenFleet Therapeutics, Echemi, and CorEnergy Semiconductor. Shanjin Capital's approach combines internationalization with flexible systems to achieve the organic unity of shareholder value, business value, and social value. Shanjin Capital is a private equity firm based in Shanghai, China, specializing in investments within the healthcare and technology sectors. The firm is approved by the Asset Management Association of China and primarily invests in clean energy, connected vehicles, medtech, and healthcare. Shanjin Capital's portfolio includes companies in biotechnology, artificial intelligence, robotics, semiconductor, electronics, telecommunications, and wireless communications infrastructure. The firm engages in various investment stages, including seed, early stage, series A, series B, growth, late stage, pre-IPO, buyout, turnaround, and distressed investments, with a geographical focus on China. Shanjin Capital's investment strategy emphasizes value creation and return on investment, leveraging its international presence and flexible systems to align shareholder, business, and social values. The firm has a track record of active investments, with recent deals in companies such as GenFleet Therapeutics, Echemi, and CorEnergy Semiconductor. Shanjin Capital's approach combines internationalization with flexible systems to achieve the organic unity of shareholder value, business value, and social value.

Investment Focus

Focus on healthcare and technology sectors
Interest in clean energy, connected vehicles, medtech, and healthcare
Engagement in various investment stages from seed to distressed investments
Geographical focus on China
Emphasis on value creation and return on investment
Alignment of shareholder, business, and social values
Active involvement in portfolio companies
Flexible investment strategies to adapt to market changes
Commitment to long-term growth and sustainability
Willingness to invest in both established companies and startups

Get the full list of 54,000+ investors

Shanjin Capital and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription

All 54,000+ investors — VC firms, private equity, family offices and angels
The key person to contact at each one, with their job title
Their work email address
Their phone number
Their LinkedIn profile
Delivered as a single .xlsx file — download it as many times as you like

Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Shanjin Capital

What sectors does Shanjin Capital invest in?

Shanjin Capital invests in Technology, Healthcare, Telecommunications, Artificial Intelligence, Medtech and Robotics, and is based in China. Shanjin Capital is listed as a private equity in the ConnectSafely investor database.